Updated 2023-06-01
Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
---|---|---|---|---|---|
Lyell Immunopharma Inc | LYEL | 0 | 0 | 0 | 0.0 |
RAPT Therapeutics Inc | RAPT | 4 | 4 | 0 | 0.0 |
Bellus Health Inc | BLU | 2 | 1 | 1 | 50.0 |
Anavex Life Sciences Corporation | AVXL | 3 | 3 | 0 | 0.0 |
Fulcrum Therapeutics Inc | FULC | 1 | 1 | 0 | 0.0 |
Ultragenyx Pharmaceutical Inc. | RARE | 7 | 6 | 1 | 14.3 |
NovoCure Ltd | NVCR | 6 | 6 | 0 | 0.0 |
Revolution Medicines Inc | RVMD | 2 | 2 | 0 | 0.0 |
Sangamo Therapeutics Inc | SGMO | 2 | 2 | 0 | 0.0 |
Cytek BioSciences Inc | CTKB | 3 | 3 | 0 | 0.0 |
Abcam - ADR (Sponsored) | ABCM | 13 | 13 | 0 | 0.0 |
BioNTech SE - ADR | BNTX | 6 | 6 | 0 | 0.0 |
Adma Biologics Inc | ADMA | 4 | 2 | 2 | 50.0 |
Biogen Inc | BIIB | 6 | 5 | 1 | 16.7 |
Biohaven Ltd | BHVN | 1 | 1 | 0 | 0.0 |
Merus N.V | MRUS | 2 | 2 | 0 | 0.0 |
Amylyx Pharmaceuticals Inc | AMLX | 3 | 1 | 2 | 66.7 |
Adaptive Biotechnologies Corp | ADPT | 10 | 10 | 0 | 0.0 |
Halozyme Therapeutics Inc. | HALO | 3 | 2 | 1 | 33.3 |
Absci Corp | ABSI | 2 | 1 | 1 | 50.0 |
Allakos Inc | ALLK | 4 | 4 | 0 | 0.0 |
Cullinan Oncology Inc | CGEM | 0 | 0 | 0 | 0.0 |
Ardelyx Inc | ARDX | 3 | 1 | 2 | 66.7 |
Karuna Therapeutics Inc | KRTX | 2 | 1 | 1 | 50.0 |
Regeneron Pharmaceuticals, Inc. | REGN | 5 | 3 | 2 | 40.0 |
Lineage Cell Therapeutics Inc | LCTX | 1 | 1 | 0 | 0.0 |
Gossamer Bio Inc | GOSS | 3 | 3 | 0 | 0.0 |
Tarsus Pharmaceuticals Inc | TARS | 2 | 1 | 1 | 50.0 |
Avidity Biosciences Inc | RNA | 3 | 3 | 0 | 0.0 |
Monte Rosa Therapeutics Inc | GLUE | 0 | 0 | 0 | 0.0 |
Intra-Cellular Therapies Inc | ITCI | 3 | 1 | 2 | 66.7 |
Allogene Therapeutics Inc | ALLO | 3 | 3 | 0 | 0.0 |
Seagen Inc | SGEN | 6 | 3 | 3 | 50.0 |
Moderna Inc | MRNA | 9 | 9 | 0 | 0.0 |
Agenus Inc | AGEN | 1 | 1 | 0 | 0.0 |
Cerevel Therapeutics Holdings Inc | CERE | 5 | 5 | 0 | 0.0 |
POINT Biopharma Global Inc | PNT | 4 | 4 | 0 | 0.0 |
Mirati Therapeutics Inc | MRTX | 5 | 5 | 0 | 0.0 |
Celldex Therapeutics Inc. | CLDX | 5 | 5 | 0 | 0.0 |
Cara Therapeutics Inc | CARA | 2 | 2 | 0 | 0.0 |
Morphic Holding Inc | MORF | 5 | 4 | 1 | 20.0 |
Fate Therapeutics Inc | FATE | 2 | 2 | 0 | 0.0 |
Gilead Sciences, Inc. | GILD | 11 | 5 | 6 | 54.5 |
Twist Bioscience Corp | TWST | 8 | 8 | 0 | 0.0 |
Keros Therapeutics Inc | KROS | 3 | 1 | 2 | 66.7 |
ARS Pharmaceuticals Inc | SPRY | 3 | 2 | 1 | 33.3 |
PTC Therapeutics Inc | PTCT | 4 | 3 | 1 | 25.0 |
Insmed Inc | INSM | 6 | 6 | 0 | 0.0 |
Adaptimmune Therapeutics Plc - ADR | ADAP | 2 | 2 | 0 | 0.0 |
Immunovant Inc | IMVT | 6 | 3 | 3 | 50.0 |
BridgeBio Pharma Inc | BBIO | 5 | 4 | 1 | 20.0 |
DICE Therapeutics Inc | DICE | 2 | 1 | 1 | 50.0 |
Ideaya Biosciences Inc | IDYA | 3 | 1 | 2 | 66.7 |
DBV Technologies - ADR | DBVT | 14 | 12 | 2 | 14.3 |
AMGEN Inc. | AMGN | 8 | 8 | 0 | 0.0 |
Voyager Therapeutics Inc | VYGR | 2 | 0 | 2 | 100.0 |
Catalyst Pharmaceuticals Inc | CPRX | 6 | 4 | 2 | 33.3 |
Poseida Therapeutics Inc | PSTX | 4 | 4 | 0 | 0.0 |
Anika Therapeutics Inc. | ANIK | 1 | 1 | 0 | 0.0 |
Vanda Pharmaceuticals Inc | VNDA | 2 | 2 | 0 | 0.0 |
Kura Oncology Inc | KURA | 1 | 1 | 0 | 0.0 |
Kodiak Sciences Inc | KOD | 4 | 4 | 0 | 0.0 |
Illumina Inc | ILMN | 10 | 10 | 0 | 0.0 |
Galapagos NV - ADR | GLPG | 17 | 16 | 1 | 5.9 |
Vaxcyte Inc | PCVX | 4 | 1 | 3 | 75.0 |
Rocket Pharmaceuticals Inc | RCKT | 5 | 3 | 2 | 40.0 |
Macrogenics Inc | MGNX | 4 | 4 | 0 | 0.0 |
Opko Health Inc | OPK | 1 | 1 | 0 | 0.0 |
Bluebird bio Inc | BLUE | 4 | 4 | 0 | 0.0 |
UroGen Pharma Ltd | URGN | 3 | 3 | 0 | 0.0 |
Agios Pharmaceuticals Inc | AGIO | 4 | 3 | 1 | 25.0 |
Sutro Biopharma Inc | STRO | 2 | 2 | 0 | 0.0 |
Verona Pharma Plc - ADR | VRNA | 3 | 0 | 3 | 100.0 |
BioXcel Therapeutics Inc | BTAI | 5 | 4 | 1 | 20.0 |
ImmunityBio Inc | IBRX | 3 | 3 | 0 | 0.0 |
FibroGen Inc | FGEN | 6 | 6 | 0 | 0.0 |
Incyte Corp. | INCY | 4 | 4 | 0 | 0.0 |
Ginkgo Bioworks Holdings Inc - Class A | DNA | 2 | 2 | 0 | 0.0 |
Medpace Holdings Inc | MEDP | 12 | 11 | 1 | 8.3 |
Foghorn Therapeutics Inc | FHTX | 2 | 1 | 1 | 50.0 |
Nuvation Bio Inc - Class A | NUVB | 0 | 0 | 0 | 0.0 |
Novavax, Inc. | NVAX | 2 | 2 | 0 | 0.0 |
Prometheus Biosciences Inc | RXDX | 6 | 3 | 3 | 50.0 |
Blueprint Medicines Corp | BPMC | 5 | 5 | 0 | 0.0 |
Phathom Pharmaceuticals Inc | PHAT | 5 | 4 | 1 | 20.0 |
MeiraGTx Holdings plc | MGTX | 1 | 1 | 0 | 0.0 |
Erasca Inc | ERAS | 1 | 1 | 0 | 0.0 |
Ligand Pharmaceuticals, Inc. - Class B | LGND | 11 | 11 | 0 | 0.0 |
Sarepta Therapeutics Inc | SRPT | 5 | 3 | 2 | 40.0 |
Bio-Techne Corp | TECH | 9 | 9 | 0 | 0.0 |
ATAI Life Sciences N.V. | ATAI | 5 | 4 | 1 | 20.0 |
Ironwood Pharmaceuticals Inc - Class A | IRWD | 3 | 3 | 0 | 0.0 |
Olink Holding AB (publ) - ADR | OLK | 2 | 2 | 0 | 0.0 |
Selecta Biosciences Inc | SELB | 3 | 3 | 0 | 0.0 |
Enanta Pharmaceuticals Inc | ENTA | 1 | 1 | 0 | 0.0 |
Coherus Biosciences Inc | CHRS | 2 | 2 | 0 | 0.0 |
Akoya Biosciences Inc | AKYA | 1 | 1 | 0 | 0.0 |
uniQure N.V. | QURE | 7 | 5 | 2 | 28.6 |
Aclaris Therapeutics Inc | ACRS | 2 | 2 | 0 | 0.0 |
Century Therapeutics Inc | IPSC | 0 | 0 | 0 | 0.0 |
Mirum Pharmaceuticals Inc | MIRM | 2 | 2 | 0 | 0.0 |
Ionis Pharmaceuticals Inc | IONS | 5 | 5 | 0 | 0.0 |
Mannkind Corp | MNKD | 2 | 1 | 1 | 50.0 |
CRISPR Therapeutics AG | CRSP | 8 | 7 | 1 | 12.5 |
IQVIA Holdings Inc | IQV | 13 | 13 | 0 | 0.0 |
United Therapeutics Corp | UTHR | 3 | 3 | 0 | 0.0 |
Recursion Pharmaceuticals Inc - Class A | RXRX | 4 | 4 | 0 | 0.0 |
Xencor Inc | XNCR | 4 | 3 | 1 | 25.0 |
Evelo Biosciences Inc | EVLO | 0 | 0 | 0 | 0.0 |
Invitae Corp | NVTA | 3 | 3 | 0 | 0.0 |
Apellis Pharmaceuticals Inc | APLS | 6 | 3 | 3 | 50.0 |
BeiGene Ltd - ADR | BGNE | 16 | 16 | 0 | 0.0 |
MaxCyte Inc | MXCT | 2 | 2 | 0 | 0.0 |
Syneos Health Inc - Class A | SYNH | 10 | 7 | 3 | 30.0 |
Quanterix Corp | QTRX | 8 | 8 | 0 | 0.0 |
Graphite Bio Inc | GRPH | 2 | 1 | 1 | 50.0 |
Iovance Biotherapeutics Inc | IOVA | 9 | 8 | 1 | 11.1 |
PepGen Inc | PEPG | 5 | 4 | 1 | 20.0 |
Travere Therapeutics Inc | TVTX | 3 | 3 | 0 | 0.0 |
Kiniksa Pharmaceuticals Ltd - Class A | KNSA | 6 | 6 | 0 | 0.0 |
Roivant Sciences Ltd | ROIV | 1 | 0 | 1 | 100.0 |
Arvinas Inc | ARVN | 5 | 5 | 0 | 0.0 |
Nektar Therapeutics | NKTR | 2 | 2 | 0 | 0.0 |
Myriad Genetics, Inc. | MYGN | 8 | 5 | 3 | 37.5 |
Adicet Bio Inc | ACET | 3 | 3 | 0 | 0.0 |
Intellia Therapeutics Inc | NTLA | 7 | 7 | 0 | 0.0 |
Rhythm Pharmaceuticals Inc. | RYTM | 1 | 1 | 0 | 0.0 |
Acumen Pharmaceuticals Inc | ABOS | 1 | 1 | 0 | 0.0 |
Caribou Biosciences Inc | CRBU | 2 | 2 | 0 | 0.0 |
Kinnate Biopharma Inc | KNTE | 1 | 1 | 0 | 0.0 |
Stevanato Group Spa | STVN | 1 | 1 | 0 | 0.0 |
Arcellx Inc | ACLX | 6 | 4 | 2 | 33.3 |
Exact Sciences Corp. | EXAS | 12 | 8 | 4 | 33.3 |
Bruker Corp | BRKR | 6 | 6 | 0 | 0.0 |
Replimune Group Inc | REPL | 4 | 4 | 0 | 0.0 |
Gritstone Bio Inc | GRTS | 1 | 1 | 0 | 0.0 |
IVERIC bio Inc | ISEE | 11 | 5 | 6 | 54.5 |
Arrowhead Pharmaceuticals Inc. | ARWR | 6 | 4 | 2 | 33.3 |
Reata Pharmaceuticals Inc - Class A | RETA | 9 | 6 | 3 | 33.3 |
Veracyte Inc | VCYT | 7 | 6 | 1 | 14.3 |
Zymeworks BC Inc | ZYME | 4 | 3 | 1 | 25.0 |
Repligen Corp. | RGEN | 14 | 14 | 0 | 0.0 |
CTI BioPharma Corp | CTIC | 3 | 1 | 2 | 66.7 |
Sana Biotechnology Inc | SANA | 5 | 4 | 1 | 20.0 |
Terns Pharmaceuticals Inc | TERN | 6 | 3 | 3 | 50.0 |
Stoke Therapeutics Inc | STOK | 6 | 6 | 0 | 0.0 |
Alpine Immune Sciences Inc | ALPN | 7 | 6 | 1 | 14.3 |
SpringWorks Therapeutics Inc | SWTX | 1 | 1 | 0 | 0.0 |
Ngm Biopharmaceuticals Inc | NGM | 2 | 2 | 0 | 0.0 |
Denali Therapeutics Inc | DNLI | 6 | 5 | 1 | 16.7 |
Prelude Therapeutics Inc | PRLD | 2 | 2 | 0 | 0.0 |
Arcus Biosciences Inc | RCUS | 5 | 4 | 1 | 20.0 |
Dynavax Technologies Corp. | DVAX | 2 | 2 | 0 | 0.0 |
Cytokinetics Inc | CYTK | 1 | 1 | 0 | 0.0 |
Abbvie Inc | ABBV | 12 | 12 | 0 | 0.0 |
Protagonist Therapeutics Inc | PTGX | 4 | 3 | 1 | 25.0 |
AnaptysBio Inc | ANAB | 4 | 4 | 0 | 0.0 |
Neurocrine Biosciences, Inc. | NBIX | 2 | 2 | 0 | 0.0 |
CureVac N.V. | CVAC | 6 | 6 | 0 | 0.0 |
Editas Medicine Inc | EDIT | 5 | 5 | 0 | 0.0 |
Autolus Therapeutics plc - ADR | AUTL | 1 | 1 | 0 | 0.0 |
BioAtla Inc | BCAB | 3 | 3 | 0 | 0.0 |
Sage Therapeutics Inc | SAGE | 3 | 1 | 2 | 66.7 |
Inovio Pharmaceuticals Inc | INO | 1 | 1 | 0 | 0.0 |
Charles River Laboratories International Inc. | CRL | 9 | 9 | 0 | 0.0 |
AbCellera Biologics Inc | ABCL | 5 | 5 | 0 | 0.0 |
Alaunos Therapeutics Inc | TCRT | 3 | 3 | 0 | 0.0 |
Akero Therapeutics Inc | AKRO | 2 | 0 | 2 | 100.0 |
Zentalis Pharmaceuticals Inc | ZNTL | 3 | 3 | 0 | 0.0 |
Verve Therapeutics Inc | VERV | 3 | 3 | 0 | 0.0 |
Theravance Biopharma Inc | TBPH | 3 | 3 | 0 | 0.0 |
Wave Life Sciences Ltd. | WVE | 3 | 2 | 1 | 33.3 |
Alnylam Pharmaceuticals Inc | ALNY | 4 | 3 | 1 | 25.0 |
Design Therapeutics Inc | DSGN | 4 | 4 | 0 | 0.0 |
Cogent Biosciences Inc | COGT | 4 | 3 | 1 | 25.0 |
Horizon Therapeutics Plc | HZNP | 5 | 2 | 3 | 60.0 |
Atara Biotherapeutics Inc | ATRA | 1 | 1 | 0 | 0.0 |
Viking Therapeutics Inc | VKTX | 4 | 2 | 2 | 50.0 |
Centessa Pharmaceuticals plc - ADR | CNTA | 3 | 3 | 0 | 0.0 |
Nuvalent Inc - Class A | NUVL | 4 | 2 | 2 | 50.0 |
Nautilus Biotechnology Inc | NAUT | 0 | 0 | 0 | 0.0 |
Immunogen, Inc. | IMGN | 5 | 2 | 3 | 60.0 |
2seventy bio Inc | TSVT | 2 | 2 | 0 | 0.0 |
Arcutis Biotherapeutics Inc | ARQT | 4 | 4 | 0 | 0.0 |
Scholar Rock Holding Corp | SRRK | 6 | 6 | 0 | 0.0 |
Immunocore Holdings plc - ADR | IMCR | 0 | 0 | 0 | 0.0 |
C4 Therapeutics Inc | CCCC | 2 | 2 | 0 | 0.0 |
Dyne Therapeutics Inc | DYN | 1 | 1 | 0 | 0.0 |
Axsome Therapeutics Inc | AXSM | 7 | 5 | 2 | 28.6 |
Invivyd Inc | IVVD | 2 | 2 | 0 | 0.0 |
PMV Pharmaceuticals Inc | PMVP | 1 | 1 | 0 | 0.0 |
Revance Therapeutics Inc | RVNC | 6 | 4 | 2 | 33.3 |
Beam Therapeutics Inc | BEAM | 4 | 4 | 0 | 0.0 |
Nanostring Technologies Inc | NSTG | 9 | 9 | 0 | 0.0 |
Emergent Biosolutions Inc | EBS | 8 | 8 | 0 | 0.0 |
Nurix Therapeutics Inc | NRIX | 2 | 2 | 0 | 0.0 |
Genmab - ADR | GMAB | 27 | 21 | 6 | 22.2 |
Pacific Biosciences of California Inc | PACB | 5 | 5 | 0 | 0.0 |
Acadia Pharmaceuticals Inc | ACAD | 5 | 4 | 1 | 20.0 |
10x Genomics Inc - Class A | TXG | 9 | 9 | 0 | 0.0 |
Xenon Pharmaceuticals Inc | XENE | 5 | 5 | 0 | 0.0 |
Biomea Fusion Inc | BMEA | 4 | 1 | 3 | 75.0 |
IGM Biosciences Inc | IGMS | 5 | 5 | 0 | 0.0 |
Gracell Biotechnologies Inc - ADR | GRCL | 0 | 0 | 0 | 0.0 |
Omega Therapeutics Inc | OMGA | 2 | 2 | 0 | 0.0 |
Regenxbio Inc | RGNX | 8 | 8 | 0 | 0.0 |
Intercept Pharmaceuticals Inc | ICPT | 4 | 4 | 0 | 0.0 |
Kymera Therapeutics Inc | KYMR | 6 | 5 | 1 | 16.7 |
Caredx Inc | CDNA | 4 | 4 | 0 | 0.0 |
Affimed N.V. | AFMD | 3 | 3 | 0 | 0.0 |
TG Therapeutics Inc | TGTX | 7 | 3 | 4 | 57.1 |
Generation Bio Co | GBIO | 4 | 4 | 0 | 0.0 |
Viridian Therapeutics Inc | VRDN | 6 | 5 | 1 | 16.7 |
Natera Inc | NTRA | 7 | 6 | 1 | 14.3 |
Legend Biotech Corp - ADR | LEGN | 6 | 3 | 3 | 50.0 |
Prothena Corporation plc | PRTA | 5 | 3 | 2 | 40.0 |
Adc Therapeutics SA | ADCT | 3 | 3 | 0 | 0.0 |
Avid Bioservices Inc | CDMO | 5 | 5 | 0 | 0.0 |
Day One Biopharmaceuticals Inc | DAWN | 3 | 2 | 1 | 33.3 |
Zai Lab Limited - ADR | ZLAB | 15 | 14 | 1 | 6.7 |
Inhibrx Inc | INBX | 3 | 3 | 0 | 0.0 |
Cymabay Therapeutics Inc | CBAY | 6 | 5 | 1 | 16.7 |
Arbutus Biopharma Corp | ABUS | 2 | 2 | 0 | 0.0 |
Immuneering Corp Class A | IMRX | 1 | 1 | 0 | 0.0 |
I-Mab - ADR | IMAB | 2 | 2 | 0 | 0.0 |
Fulgent Genetics Inc | FLGT | 3 | 2 | 1 | 33.3 |
Seer Inc - Class A | SEER | 6 | 6 | 0 | 0.0 |
Actinium Pharmaceuticals Inc | ATNM | 2 | 1 | 1 | 50.0 |
Grifols SA - ADR - Level III | GRFS | 16 | 12 | 4 | 25.0 |
Argen X SE - ADR | ARGX | 8 | 7 | 1 | 12.5 |
Edgewise Therapeutics Inc | EWTX | 4 | 4 | 0 | 0.0 |
Kezar Life Sciences Inc | KZR | 3 | 3 | 0 | 0.0 |
MiNK Therapeutics Inc | INKT | 5 | 5 | 0 | 0.0 |
ITeos Therapeutics Inc | ITOS | 2 | 2 | 0 | 0.0 |
Waters Corp. | WAT | 13 | 13 | 0 | 0.0 |
Syndax Pharmaceuticals Inc | SNDX | 3 | 3 | 0 | 0.0 |
Mettler-Toledo International, Inc. | MTD | 10 | 9 | 1 | 10.0 |
Altimmune Inc | ALT | 3 | 3 | 0 | 0.0 |
Exelixis Inc | EXEL | 6 | 5 | 1 | 16.7 |
Madrigal Pharmaceuticals Inc | MDGL | 5 | 3 | 2 | 40.0 |
Eiger BioPharmaceuticals Inc | EIGR | 2 | 2 | 0 | 0.0 |
Vericel Corp | VCEL | 3 | 3 | 0 | 0.0 |
GreenLight Biosciences Inc | GRNA | 3 | 2 | 1 | 33.3 |
Castle Biosciences Inc | CSTL | 8 | 6 | 2 | 25.0 |
Precigen Inc | PGEN | 3 | 3 | 0 | 0.0 |
Maravai LifeSciences Holdings Inc - Class A | MRVI | 5 | 5 | 0 | 0.0 |
4D Molecular Therapeutics Inc | FDMT | 3 | 3 | 0 | 0.0 |
G1 Therapeutics Inc | GTHX | 4 | 4 | 0 | 0.0 |
Deciphera Pharmaceuticals Inc | DCPH | 4 | 4 | 0 | 0.0 |
Mimedx Group Inc | MDXG | 2 | 1 | 1 | 50.0 |
Repare Therapeutics Inc | RPTX | 4 | 4 | 0 | 0.0 |
Alx Oncology Holdings Inc | ALXO | 2 | 2 | 0 | 0.0 |
Krystal Biotech Inc | KRYS | 6 | 3 | 3 | 50.0 |
EQRx Inc | EQRX | 3 | 3 | 0 | 0.0 |
Humacyte Inc | HUMA | 1 | 1 | 0 | 0.0 |
Ascendis Pharma A/S - ADR | ASND | 1 | 1 | 0 | 0.0 |
Tango Therapeutics Inc | TNGX | 4 | 4 | 0 | 0.0 |
Amicus Therapeutics Inc | FOLD | 4 | 3 | 1 | 25.0 |
Instil Bio Inc | TIL | 1 | 1 | 0 | 0.0 |
89bio Inc | ETNB | 5 | 3 | 2 | 40.0 |
Summit Therapeutics Inc | SMMT | 3 | 2 | 1 | 33.3 |
Relay Therapeutics Inc | RLAY | 3 | 3 | 0 | 0.0 |
Chinook Therapeutics Inc | KDNY | 5 | 5 | 0 | 0.0 |
Biocryst Pharmaceuticals Inc. | BCRX | 4 | 3 | 1 | 25.0 |
Scilex Holding Company | SCLX | 3 | 2 | 1 | 33.3 |
Annexon Inc | ANNX | 6 | 6 | 0 | 0.0 |
Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 6 | 5 | 1 | 16.7 |
Pliant Therapeutics Inc | PLRX | 4 | 3 | 1 | 25.0 |
AlloVir Inc | ALVR | 5 | 5 | 0 | 0.0 |
Atea Pharmaceuticals Inc | AVIR | 1 | 0 | 1 | 100.0 |
Codexis Inc. | CDXS | 6 | 6 | 0 | 0.0 |
Vertex Pharmaceuticals, Inc. | VRTX | 3 | 2 | 1 | 33.3 |
Marinus Pharmaceuticals Inc | MRNS | 2 | 0 | 2 | 100.0 |
Alector Inc | ALEC | 4 | 3 | 1 | 25.0 |
Seres Therapeutics Inc | MCRB | 0 | 0 | 0 | 0.0 |
Crinetics Pharmaceuticals Inc | CRNX | 3 | 2 | 1 | 33.3 |
Alkermes plc | ALKS | 4 | 3 | 1 | 25.0 |
Geron Corp. | GERN | 2 | 1 | 1 | 50.0 |
Compass Pathways Plc - ADR | CMPS | 2 | 2 | 0 | 0.0 |
Vir Biotechnology Inc | VIR | 5 | 5 | 0 | 0.0 |
Mersana Therapeutics Inc | MRSN | 7 | 5 | 2 | 28.6 |
Bicycle Therapeutics Plc - ADR | BCYC | 2 | 2 | 0 | 0.0 |
Arcturus Therapeutics Holdings Inc | ARCT | 4 | 3 | 1 | 25.0 |
Aurinia Pharmaceuticals Inc | AUPH | 5 | 3 | 2 | 40.0 |
Ventyx Biosciences Inc | VTYX | 5 | 2 | 3 | 60.0 |
Karyopharm Therapeutics Inc | KPTI | 3 | 3 | 0 | 0.0 |
Nkarta Inc | NKTX | 5 | 5 | 0 | 0.0 |
Exscientia Plc - ADR | EXAI | 4 | 4 | 0 | 0.0 |